Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 29, 2015 4:07 PM ET

Capital Markets

Company Overview of Flagship Ventures

Company Overview

Flagship Ventures is a private equity and venture capital firm specializing in incubation, seed stage, early, later and growth stage investments. The firm prefers to invest in the healthcare including biotherapeutics, life sciences, medical technologies, and biological discoveries leading to new therapies, advanced analysis for improved medicine, chemistries and small molecule drugs, nanotechnology for medicine; energy efficiency; bioenergy; sustainability, focusing on energy, water, and agriculture/nutrition; and clean technology sector. The firm seeks to invest in Midwest, focusing on investing nationally. It seeks to initially invest between $500,000 and $5 million, with a typical investm...

One Memorial Drive

7th Floor

Cambridge, MA 02142

United States

Founded in 2000





Key Executives for Flagship Ventures

Co-Founder, Senior Managing Partner, and Chief Executive Officer
Age: 52
Co-Founder and Managing Partner
Age: 58
Chief Financial Officer and Controller
Age: 44
Chief Operating Officer, Partner, and General Partner
Age: 62
Partner and Chief Business Officer
Age: 61
Compensation as of Fiscal Year 2015.

Flagship Ventures Key Developments

Flagship Ventures Presents at HighQuest Partners, LLC's 7th Annual Global AgInvesting Conference, Apr-30-2015 09:00 AM

Flagship Ventures Presents at HighQuest Partners, LLC's 7th Annual Global AgInvesting Conference, Apr-30-2015 09:00 AM. Venue: Waldorf Astoria, 301 Park Avenue, New York, NY 10022, United States. Speakers: Ignacio Martinez, Partner.

Flagship Ventures Presents at Boston CEO Conference, May-27-2015 10:50 AM

Flagship Ventures Presents at Boston CEO Conference, May-27-2015 10:50 AM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: David A. Berry, General Partner.

Flagship Ventures Announces Executive Promotions

Flagship Ventures announced that Douglas Cole, M.D., has been promoted to managing partner and David Berry, M.D. Ph.D., has been promoted to general partner. Dr. Cole has led investments in Agios Pharmaceuticals, CombinatoRx (ZLCS), Concert Pharmaceuticals (CNCE), Editas Medicine, Receptos, Quanterix, Syros Pharmaceuticals and Tetraphase Pharmaceuticals. Dr. Berry has led several investments and is a co-founder of portfolio companies Joule Unlimited, Eleven Biotherapeutics (EBIO), Seres Health, and Pronutria Biosciences.

Similar Private Companies By Industry

Company Name Region
Greater China Acquisition Corp. United States
Palomino Capital LLC United States
Mason Forty Partners LLC United States
M. Griffith Investment Services, Inc. United States
Tom and Nancy Juda Living Trust United States

Recent Private Companies Transactions

Private Placement
August 10, 2015
Editas Medicine Inc.
Private Placement
May 14, 2015
Denali Therapeutics Inc.
Private Placement
May 12, 2015
BG Medicine, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Flagship Ventures, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at